Isofol Medical Ab Stock Net Income
| 5IU Stock | EUR 0.05 0 5.82% |
As of the 1st of February, ISOFOL MEDICAL retains the risk adjusted performance of 0.0345, and Market Risk Adjusted Performance of 0.2089. ISOFOL MEDICAL technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out ISOFOL MEDICAL AB coefficient of variation, jensen alpha, potential upside, as well as the relationship between the variance and maximum drawdown to decide if ISOFOL MEDICAL is priced correctly, providing market reflects its last-minute price of 0.0502 per share.
ISOFOL MEDICAL's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing ISOFOL MEDICAL's valuation are provided below:Gross Profit -41.9 M | Market Capitalization 18.1 M | Enterprise Value Revenue 0.0389 | Earnings Share (0.02) | Quarterly Revenue Growth (1.00) |
ISOFOL |
ISOFOL MEDICAL 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ISOFOL MEDICAL's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ISOFOL MEDICAL.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in ISOFOL MEDICAL on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding ISOFOL MEDICAL AB or generate 0.0% return on investment in ISOFOL MEDICAL over 90 days. ISOFOL MEDICAL is related to or competes with New Residential, Sixt Leasing, CanSino Biologics, Air Lease, ScanSource, Gladstone Investment, and Virtus Investment. Isofol Medical AB , a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and i... More
ISOFOL MEDICAL Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ISOFOL MEDICAL's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ISOFOL MEDICAL AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.14 | |||
| Information Ratio | 0.0273 | |||
| Maximum Drawdown | 37.47 | |||
| Value At Risk | (3.99) | |||
| Potential Upside | 6.35 |
ISOFOL MEDICAL Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ISOFOL MEDICAL's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ISOFOL MEDICAL's standard deviation. In reality, there are many statistical measures that can use ISOFOL MEDICAL historical prices to predict the future ISOFOL MEDICAL's volatility.| Risk Adjusted Performance | 0.0345 | |||
| Jensen Alpha | 0.1473 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.028 | |||
| Treynor Ratio | 0.1989 |
ISOFOL MEDICAL February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0345 | |||
| Market Risk Adjusted Performance | 0.2089 | |||
| Mean Deviation | 3.2 | |||
| Semi Deviation | 4.88 | |||
| Downside Deviation | 5.14 | |||
| Coefficient Of Variation | 2794.73 | |||
| Standard Deviation | 5.27 | |||
| Variance | 27.8 | |||
| Information Ratio | 0.0273 | |||
| Jensen Alpha | 0.1473 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.028 | |||
| Treynor Ratio | 0.1989 | |||
| Maximum Drawdown | 37.47 | |||
| Value At Risk | (3.99) | |||
| Potential Upside | 6.35 | |||
| Downside Variance | 26.39 | |||
| Semi Variance | 23.8 | |||
| Expected Short fall | (3.49) | |||
| Skewness | 0.3946 | |||
| Kurtosis | 7.08 |
ISOFOL MEDICAL AB Backtested Returns
At this point, ISOFOL MEDICAL is out of control. ISOFOL MEDICAL AB holds Efficiency (Sharpe) Ratio of 0.0401, which attests that the entity had a 0.0401 % return per unit of volatility over the last 3 months. We have found twenty-six technical indicators for ISOFOL MEDICAL AB, which you can use to evaluate the volatility of the firm. Please check out ISOFOL MEDICAL's risk adjusted performance of 0.0345, and Market Risk Adjusted Performance of 0.2089 to validate if the risk estimate we provide is consistent with the expected return of 0.11%. ISOFOL MEDICAL has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.9, which attests to possible diversification benefits within a given portfolio. ISOFOL MEDICAL returns are very sensitive to returns on the market. As the market goes up or down, ISOFOL MEDICAL is expected to follow. ISOFOL MEDICAL AB currently retains a risk of 2.76%. Please check out ISOFOL MEDICAL sortino ratio, potential upside, and the relationship between the jensen alpha and maximum drawdown , to decide if ISOFOL MEDICAL will be following its current trending patterns.
Auto-correlation | 0.00 |
No correlation between past and present
ISOFOL MEDICAL AB has no correlation between past and present. Overlapping area represents the amount of predictability between ISOFOL MEDICAL time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ISOFOL MEDICAL AB price movement. The serial correlation of 0.0 indicates that just 0.0% of current ISOFOL MEDICAL price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, ISOFOL MEDICAL AB reported net income of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The net income for all Germany stocks is 100.0% higher than that of the company.
ISOFOL Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ISOFOL MEDICAL's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ISOFOL MEDICAL could also be used in its relative valuation, which is a method of valuing ISOFOL MEDICAL by comparing valuation metrics of similar companies.ISOFOL MEDICAL is currently under evaluation in net income category among its peers.
ISOFOL Fundamentals
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | 5.21 M | ||||
| Shares Outstanding | 281.11 M | ||||
| Shares Owned By Insiders | 28.08 % | ||||
| Shares Owned By Institutions | 9.82 % | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 41.24 X | ||||
| Gross Profit | (41.91 M) | ||||
| EBITDA | (55.89 M) | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | 0.43 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Beta | 0.92 | ||||
| Market Capitalization | 18.08 M |
About ISOFOL MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ISOFOL MEDICAL AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ISOFOL MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ISOFOL MEDICAL AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Other Information on Investing in ISOFOL Stock
ISOFOL MEDICAL financial ratios help investors to determine whether ISOFOL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ISOFOL with respect to the benefits of owning ISOFOL MEDICAL security.